|
1
|
Schacht V, Ramirez MI, Hong YK, et al:
T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature
formation and causes lymphedema. EMBO J. 22:3546–3556. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schacht V, Dadras SS, Johnson LA, Jackson
DG, Hong YK and Detmar M: Up-regulation of the lymphatic marker
podoplanin, a mucin-type transmembrane glycoprotein, in human
squamous cell carcinomas and germ cell tumors. Am J Pathol.
166:913–921. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wigle JT, Harvey N, Detmar M, et al: An
essential role for Prox1 in the induction of the lymphatic
endothelial cell phenotype. EMBO J. 21:1505–1513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Salven P, Mustjoki S, Alitalo R, Alitalo K
and Rafii S: VEGFR-3 and CD133 identify a population of
CD34+ lymphatic/vascular endothelial precursor cells.
Blood. 101:168–172. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He Y, Rajantie I, Ilmonen M, et al:
Preexisting lymphatic endothelium but not endothelial progenitor
cells are essential for tumor lymphangiogenesis and lymphatic
metastasis. Cancer Res. 64:3737–3740. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kerjaschki D: The crucial role of
macrophages in lymphangiogenesis. J Clin Invest. 115:2316–2319.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ji RC and Kato S: Lymphatic network and
lymphangiogenesis in the gastric wall. J Histochem Cytochem.
51:331–338. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mattila MM, Ruohola JK, Karpanen T,
Jackson DG, Alitalo K and Harkonen PL: VEGF-C induced
lymphangiogenesis is associated with lymph node metastasis in
orthotopic MCF-7 tumors. Int J Cancer. 98:946–951. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Franchi A, Massi D, Santucci M, et al:
Inducible nitric oxide synthase activity correlates with
lymphangiogenesis and vascular endothelial growth factor-C
expression in head and neck squamous cell carcinoma. J Pathol.
208:439–445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koike C, McKee TD, Pluen A, et al: Solid
stress facilitates spheroid formation: potential involvement of
hyaluronan. Br J Cancer. 86:947–953. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kato S, Shimoda H, Ji RC and Miura M:
Lymphangiogenesis and expression of specific molecules as lymphatic
endothelial cell markers. Anat Sci Int. 81:71–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maula SM, Luukkaa M, Grenman R, Jackson D,
Jalkanen S and Ristamaki R: Intratumoral lymphatics are essential
for the metastatic spread and prognosis in squamous cell carcinomas
of the head and neck region. Cancer Res. 63:1920–1926. 2003.
|
|
13
|
Sipos B, Klapper W, Kruse ML, Kalthoff H,
Kerjaschki D and Kloppel G: Expression of lymphangiogenic factors
and evidence of intratumoral lymphangiogenesis in pancreatic
endocrine tumors. Am J Pathol. 165:1187–1197. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Padera TP, Kadambi A, di Tomaso E, et al:
Lymphatic metastasis in the absence of functional intratumor
lymphatics. Science. 296:1883–1886. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Straume O, Jackson DG and Akslen LA:
Independent prognostic impact of lymphatic vessel density and
presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin
Cancer Res. 9:250–256. 2003.PubMed/NCBI
|
|
16
|
Saintigny P, Kambouchner M, Ly M, et al:
Vascular endothelial growth factor-C and its receptor VEGFR-3 in
non-small-cell lung cancer: concurrent expression in cancer cells
from primary tumour and metastatic lymph node. Lung Cancer.
58:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brakenhielm E, Burton JB, Johnson M, et
al: Modulating metastasis by a lymphangiogenic switch in prostate
cancer. Int J Cancer. 121:2153–2161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karkkainen MJ, Haiko P, Sainio K, et al:
Vascular endothelial growth factor C is required for sprouting of
the first lymphatic vessels from embryonic veins. Nat Immunol.
5:74–80. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haiko P, Makinen T, Keskitalo S, et al:
Deletion of vascular endothelial growth factor C (VEGF-C) and
VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse
embryos. Mol Cell Biol. 28:4843–4850. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stacker SA, Caesar C, Baldwin ME, et al:
VEGF-D promotes the metastatic spread of tumor cells via the
lymphatics. Nat Med. 7:186–191. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin J, Lalani AS, Harding TC, et al:
Inhibition of lymphogenous metastasis using adeno-associated
virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor.
Cancer Res. 65:6901–6909. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Makinen T, Jussila L, Veikkola T, et al:
Inhibition of lymphangiogenesis with resulting lymphedema in
transgenic mice expressing soluble VEGF receptor-3. Nat Med.
7:199–205. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saad RS, Kordunsky L, Liu YL, Denning KL,
Kandil HA and Silverman JF: Lymphatic microvessel density as
prognostic marker in colorectal cancer. Mod Pathol. 19:1317–1323.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Whitehurst B, Flister MJ, Bagaitkar J, et
al: Anti-VEGF-A therapy reduces lymphatic vessel density and
expression of VEGFR-3 in an orthotopic breast tumor model. Int J
Cancer. 121:2181–2191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cao R, Bjorndahl MA, Religa P, et al:
PDGF-BB induces intratumoral lymphangiogenesis and promotes
lymphatic metastasis. Cancer Cell. 6:333–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cao R, Bjorndahl MA, Gallego MI, et al:
Hepatocyte growth factor is a lymphangiogenic factor with an
indirect mechanism of action. Blood. 107:3531–3536. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Björndahl M, Cao R, Nissen LJ, et al:
Insulin-like growth factors 1 and 2 induce lymphangiogenesis in
vivo. Proc Natl Acad Sci USA. 102:15593–15598. 2005.PubMed/NCBI
|
|
28
|
Chang LK, Garcia-Cardena G, Farnebo F, et
al: Dose-dependent response of FGF-2 for lymphangiogenesis. Proc
Natl Acad Sci USA. 101:11658–11663. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morisada T, Oike Y, Yamada Y, et al:
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.
Blood. 105:4649–4656. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Wu K, Zhang D, et al: Expressions
and clinical significances of angiopoietin-1, -2 and Tie2 in human
gastric cancer. Biochem Biophys Res Commun. 337:386–393. 2005.
View Article : Google Scholar : PubMed/NCBI
|
